X4制药 内部交易概览
最近18个月交易的高管股东 | 交易次数 | 净买入(股) |
---|---|---|
Paula Ragan | 8 | -401,923 |
Mary Dibiase | 8 | -113,683 |
Adam S. Mostafa | 7 | -401,921 |
Arthur Taveras | 5 | -100,451 |
Michael S Wyzga | 1 | 25,000 |
Mark Baldry | 1 | -10,257 |
交易分段汇总 | 买入数量 | 卖出数量 | 净买入(股) |
---|---|---|---|
最近1个月 | 0 | 0 | 0 |
最近3个月 | 0 | 185,708 | -185,708 |
最近6个月 | 0 | 801,437 | -801,437 |
最近12个月 | 25,000 | 966,423 | -941,423 |
最近18个月 | 25,000 | 1,158,291 | -1,133,291 |
X4制药 内部交易
X4制药 最新内部交易
Arthur Taveras | Chief Scientific Officer | 2024-03-11 | 卖出 | 14,235 | 234,301 |
$0.88
|
+32.39%
|
Paula Ragan | President & CEO | 2024-03-11 | 卖出 | 49,678 | 765,068 |
$0.88
|
+32.39%
|
Adam S. Mostafa | CFO | 2024-03-11 | 卖出 | 52,500 | - |
$0.88
|
+32.39%
|
Mary Dibiase | COO | 2024-03-11 | 卖出 | 15,409 | 291,752 |
$0.88
|
+32.39%
|
Paula Ragan | President & CEO | 2024-02-12 | 卖出 | 21,695 | 814,746 |
$1.01
|
+15.35%
|
Adam S. Mostafa | CFO | 2024-02-12 | 卖出 | 27,721 | 52,500 |
$1.01
|
+15.35%
|
Mary Dibiase | COO | 2024-02-12 | 卖出 | 3,683 | 307,161 |
$1.01
|
+15.35%
|
Arthur Taveras | Chief Scientific Officer | 2024-02-12 | 卖出 | 787 | 248,536 |
$1.01
|
+15.35%
|
Paula Ragan | President & CEO | 2023-11-03 | 卖出 | 239,437 | 836,441 |
$0.76
|
+53.29%
|
Mark Baldry | Chief Commercial Officer | 2023-11-01 | 卖出 | 10,257 | 24,690 |
$0.73
|
+59.59%
|